Download Files:
Menin-MLL inhibitor 19
$860 – $7,200
Products Details
Product Description
– Menin-MLL inhibitor 19, a potent exo-aza spiro inhibitor of menin-mll interaction, example A17, extracted from patent WO2019120209A1. Menin-MLL inhibitor 19 can be used for the reseaech of various diseases, such as cancer, myelodysplastic syndrome (MDS) and diabetes[1].
Web ID
– HY-139076
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture)
Shipping
– Room Temperature
Applications
– Metabolism-protein/nucleotide metabolism
Molecular Formula
– C30H34F3N7O4S
References
– [1]Xuedong Dai, et al. Exo-aza spiro inhibitors of menin-mll interaction. Patent WO2019120209A1
CAS Number
– 2360487-93-8
Molecular Weight
– 645.70
Compound Purity
– 98.07
SMILES
– O=C(N(C1CCC2(C1)CN(C2)C3=C4C=C(CC(F)(F)F)SC4=NC=N3)CC5=CC=C6C(NC(N6CC(N)=O)=O)=C5)OC(C)(C)C
Clinical Information
– No Development Reported
Research Area
– Cancer; Metabolic Disease
Solubility
– DMSO : 200 mg/mL (ultrasonic)
Target
– Epigenetic Reader Domain
Pathway
– Epigenetics
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
